Haas SJ - Search Results

1

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.

Aw TJ, Haas SJ, Liew D, Krum H. Aw TJ, et al. Among authors: haas sj. Arch Intern Med. 2005 Mar 14;165(5):490-6. doi: 10.1001/archinte.165.5.IOI50013. Epub 2005 Feb 14. Arch Intern Med. 2005. PMID: 15710786

2

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.

Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, Forbes A, Krum H. Zimmet H, et al. Among authors: haas sj. Eur J Heart Fail. 2012 Jan;14(1):91-105. doi: 10.1093/eurjhf/hfr148. Epub 2011 Nov 6. Eur J Heart Fail. 2012. PMID: 22065869 Free article.

3

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis.

Chan CC, Reid CM, Aw TJ, Liew D, Haas SJ, Krum H. Chan CC, et al. Among authors: haas sj. J Hypertens. 2009 Dec;27(12):2332-41. doi: 10.1097/HJH.0b013e3283310dc9. J Hypertens. 2009. PMID: 19887957

4

Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.

Wein L, Wein S, Haas SJ, Shaw J, Krum H. Wein L, et al. Among authors: haas sj. Arch Intern Med. 2007 Jul 23;167(14):1476-86. doi: 10.1001/archinte.167.14.1476. Arch Intern Med. 2007. PMID: 17646601 Clinical Trial.

5

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.

Phrommintikul A, Haas SJ, Elsik M, Krum H. Phrommintikul A, et al. Among authors: haas sj. Lancet. 2007 Feb 3;369(9559):381-8. doi: 10.1016/S0140-6736(07)60194-9. Lancet. 2007. PMID: 17276778

6

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J. Krum H, et al. Among authors: haas sj. Eur Heart J. 2005 Oct;26(20):2154-8. doi: 10.1093/eurheartj/ehi409. Epub 2005 Jul 13. Eur Heart J. 2005. PMID: 16014644 Review.

7

Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

Haas SJ, Vos T, Gilbert RE, Krum H. Haas SJ, et al. Am Heart J. 2003 Nov;146(5):848-53. doi: 10.1016/S0002-8703(03)00403-4. Am Heart J. 2003. PMID: 14597934 Review.

8

Cardiovascular effects of selective cyclooxygenase-2 inhibitors.

Krum H, Liew D, Aw J, Haas S. Krum H, et al. Expert Rev Cardiovasc Ther. 2004 Mar;2(2):265-70. doi: 10.1586/14779072.2.2.265. Expert Rev Cardiovasc Ther. 2004. PMID: 15151474 Review.

9

Blood pressure effects of COX-2 inhibitors.

Krum H, Aw TJ, Liew D, Haas S. Krum H, et al. J Cardiovasc Pharmacol. 2006;47 Suppl 1:S43-8. doi: 10.1097/00005344-200605001-00008. J Cardiovasc Pharmacol. 2006. PMID: 16785828 Review.

10

Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.

Dulin BR, Haas SJ, Abraham WT, Krum H. Dulin BR, et al. Among authors: haas sj. Am J Cardiol. 2005 Apr 1;95(7):896-8. doi: 10.1016/j.amjcard.2004.11.052. Am J Cardiol. 2005. PMID: 15781028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results